153 related articles for article (PubMed ID: 30075609)
21. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
Bi J; Lyu PF; Wang Y; Zhang H
Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
[TBL] [Abstract][Full Text] [Related]
22. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
Lin HW; Bhattacharyya N
Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
[TBL] [Abstract][Full Text] [Related]
23. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
24. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
26. The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross-sectional study.
Lan Y; Cao L; Song Q; Jin Z; Xiao J; Yan L; Luo Y; Zhang M
Cancer Med; 2021 Mar; 10(6):1989-2002. PubMed ID: 33638269
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
29. Extent of surgery for papillary thyroid carcinoma: the debate continues: comment on "surgery for papillary thyroid carcinoma".
Shaha AR
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1061-3. PubMed ID: 21079157
[No Abstract] [Full Text] [Related]
30. Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
Herrera M; Hussein MH; Persons E; Alias MR; Rabee A; Sayed A; Toraih E; Kandil E
Am J Surg; 2024 Mar; 229():99-105. PubMed ID: 37989608
[TBL] [Abstract][Full Text] [Related]
31. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
32. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
33. Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis.
Xu M; Xi Z; Zhao Q; Yang W; Tan J; Yi P; Zhou J; Huang T
Front Endocrinol (Lausanne); 2023; 14():1149826. PubMed ID: 37293504
[TBL] [Abstract][Full Text] [Related]
34. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
35. The survival after thyroidectomy versus lobectomy in multifocal papillary thyroid microcarcinoma patients.
Ai X; Zhang K; Xu J; Xiao H; Li L; Sun P; Li J
Endocrine; 2024 Apr; ():. PubMed ID: 38622433
[TBL] [Abstract][Full Text] [Related]
36. Do patients with oxyphilic cell papillary thyroid carcinoma have a poor prognosis? Analysis of the surveillance, epidemiology, and end results database 2004-2013 with propensity score matching.
Liu C; Zhao Q; Zeng W; Chen C; Ming J; Wang S; Xiong Y; Zhang C; Chen T; Liu Z; Huang T
Oncotarget; 2017 Sep; 8(44):77075-77085. PubMed ID: 29100371
[TBL] [Abstract][Full Text] [Related]
37. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases.
Yu XM; Wan Y; Sippel RS; Chen H
Ann Surg; 2011 Oct; 254(4):653-60. PubMed ID: 21876434
[TBL] [Abstract][Full Text] [Related]
38. Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?
Lee YH; Lee YM; Sung TY; Yoon JH; Song DE; Kim TY; Baek JH; Ryu JS; Chung KW; Hong SJ
Ann Surg Oncol; 2017 Jul; 24(7):1958-1964. PubMed ID: 28130621
[TBL] [Abstract][Full Text] [Related]
39. Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis.
Zheng W; Li J; Lv P; Chen Z; Fan P
Eur J Surg Oncol; 2018 Nov; 44(11):1679-1684. PubMed ID: 30158063
[TBL] [Abstract][Full Text] [Related]
40. Surgery for papillary thyroid carcinoma: is lobectomy enough?
Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
